Lymphocytes Subpopulation in Cancer Patients

NCT02516371 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2015-08-26

No results posted yet for this study

Summary

This study aims to exam the subpopulation of lymphocytes and evaluate the clinico-pathologic correlations.

Conditions

Interventions

OTHER

lymphocyte

To evaluate the subpopulation of lymphocytes in cancer patients

Sponsors & Collaborators

  • DERSHENG SUN

    lead OTHER

Principal Investigators

  • Yoon Ho Ko, MD, PhD · Uijeongbu St. Mary's Hospital, The Catholic University of Korea

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2016-06-30
Completion
2018-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02516371 on ClinicalTrials.gov